Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 11:12 AM
Ignite Modification Date:
2025-12-26 @ 11:12 AM
NCT ID:
NCT00436228
Brief Summary:
SB-742510 is a semi-synthetic pleuromutilin antibiotic that is being developed for treatment of respiratory infections.
The purpose of this study is to estimate the bioavailability of four different formulations and to evaluate the safety of each of the four formulations
Study:
NCT00436228
Study Brief:
Protocol Section:
NCT00436228